6-41061695-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006789.4(APOBEC2):āc.499A>Cā(p.Lys167Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,614,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006789.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APOBEC2 | NM_006789.4 | c.499A>C | p.Lys167Gln | missense_variant | 2/3 | ENST00000244669.3 | NP_006780.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOBEC2 | ENST00000244669.3 | c.499A>C | p.Lys167Gln | missense_variant | 2/3 | 1 | NM_006789.4 | ENSP00000244669.2 | ||
OARD1 | ENST00000482853.5 | n.144+8381T>G | intron_variant | 2 | ENSP00000420472.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251386Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135868
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 727248
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 08, 2024 | The c.499A>C (p.K167Q) alteration is located in exon 2 (coding exon 2) of the APOBEC2 gene. This alteration results from a A to C substitution at nucleotide position 499, causing the lysine (K) at amino acid position 167 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at